419 related articles for article (PubMed ID: 29627655)
1. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds.
Abdellatif KRA; Bakr RB
Bioorg Chem; 2018 Aug; 78():341-357. PubMed ID: 29627655
[TBL] [Abstract][Full Text] [Related]
2. An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.
Cherukupalli S; Hampannavar GA; Chinnam S; Chandrasekaran B; Sayyad N; Kayamba F; Reddy Aleti R; Karpoormath R
Bioorg Med Chem; 2018 Jan; 26(2):309-339. PubMed ID: 29273417
[TBL] [Abstract][Full Text] [Related]
3. Functional Pyrazolo[1,5-
Arias-Gómez A; Godoy A; Portilla J
Molecules; 2021 May; 26(9):. PubMed ID: 34063043
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Cytotoxicity, Antimicrobial and Docking Simulation of Novel Pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[3,4-c] pyrimidine Derivatives.
Hassaneen HM; Saleh FM; Abdallah TA; Mohamed MF; Mohamed YS; Awad EM; Abdelhamid IA
Mini Rev Med Chem; 2019; 19(8):657-670. PubMed ID: 30332953
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR of a new series of COX-2-selective inhibitors: pyrazolo[1,5-a]pyrimidines.
Almansa C; de Arriba AF; Cavalcanti FL; Gómez LA; Miralles A; Merlos M; García-Rafanell J; Forn J
J Med Chem; 2001 Feb; 44(3):350-61. PubMed ID: 11462976
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
7. Design and Synthesis of 2-(1-Alkylaminoalkyl)pyrazolo[1,5-a]pyrimidines as New Respiratory Syncytial Virus Fusion Protein Inhibitors.
Yamaguchi-Sasaki T; Tamura Y; Ogata Y; Kawaguchi T; Kurosaka J; Sugaya Y; Iwakiri K; Busujima T; Takahashi R; Ueda-Yonemoto N; Tanigawa E; Abe-Kumasaka T; Sugiyama H; Kanuma K
Chem Pharm Bull (Tokyo); 2020; 68(4):345-362. PubMed ID: 32238652
[TBL] [Abstract][Full Text] [Related]
8. Some pyrazole and pyrazolo[3,4-d]pyrimidine derivatives: synthesis and anticancer evaluation.
Shamroukh AH; Rashad AE; Abdel-Megeid RE; Ali HS; Ali MM
Arch Pharm (Weinheim); 2014 Aug; 347(8):559-65. PubMed ID: 24801813
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines.
Rashad AE; Hegab MI; Abdel-Megeid RE; Fathalla N; Abdel-Megeid FM
Eur J Med Chem; 2009 Aug; 44(8):3285-92. PubMed ID: 19285757
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of pyrazolo[4',3':5,6]pyrano[2,3-d]pyrimidine derivatives for antiviral evaluation.
Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM
Arch Pharm (Weinheim); 2007 May; 340(5):236-43. PubMed ID: 17464958
[TBL] [Abstract][Full Text] [Related]
11. Novel pyrazolo[3,4-d]pyrimidine-based inhibitors of Staphlococcus aureus DNA polymerase III: design, synthesis, and biological evaluation.
Ali A; Taylor GE; Ellsworth K; Harris G; Painter R; Silver LL; Young K
J Med Chem; 2003 May; 46(10):1824-30. PubMed ID: 12723946
[TBL] [Abstract][Full Text] [Related]
12. Recent Applications of Triazolopyrimidine-Based Bioactive Compounds in Medicinal and Agrochemical Chemistry.
Renyu Q; Yuchao L; Kandegama WMWW; Qiong C; Guangfu Y
Mini Rev Med Chem; 2018; 18(9):781-793. PubMed ID: 29090667
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.
Bakr RB; Azouz AA; Abdellatif KR
J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522
[TBL] [Abstract][Full Text] [Related]
14. Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Ali EMH; Abdel-Maksoud MS; Oh CH
Bioorg Med Chem; 2019 Apr; 27(7):1159-1194. PubMed ID: 30826188
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
16. Pyrazolo[3,4-d]pyrimidine derivatives containing a Schiff base moiety as potential antiviral agents.
Wang YY; Xu FZ; Zhu YY; Song B; Luo D; Yu G; Chen S; Xue W; Wu J
Bioorg Med Chem Lett; 2018 Sep; 28(17):2979-2984. PubMed ID: 30122226
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimicrobial activity of some new pyrazole, fused pyrazolo[3,4-d]-pyrimidine and pyrazolo[4,3-e][1,2,4]-triazolo[1,5-c]pyrimidine derivatives.
Abunada NM; Hassaneen HM; Kandile NG; Miqdad OA
Molecules; 2008 Jul; 13(7):1501-17. PubMed ID: 18719521
[TBL] [Abstract][Full Text] [Related]
18. Key Updates on the Chemistry and Biological Roles of Thiazine Scaffold: A Review.
Choudhary S; Silakari O; Singh PK
Mini Rev Med Chem; 2018; 18(17):1452-1478. PubMed ID: 29663882
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, DNA-binding, and antiviral activity of certain pyrazolo[3,4-d]pyrimidine derivatives.
el-Bendary ER; Badria FA
Arch Pharm (Weinheim); 2000 Apr; 333(4):99-103. PubMed ID: 10816902
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities.
Abd El Razik HA; Mroueh M; Faour WH; Shebaby WN; Daher CF; Ashour HMA; Ragab HM
Chem Biol Drug Des; 2017 Jul; 90(1):83-96. PubMed ID: 28032452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
